SP110 and pancreatic adenocarcinoma: Another intriguing observation was the significant differences in the expression levels of SP100 family members across different immune subtypes of PAAD: SP100/SP110/SP140L displayed the highest expression in C2 subtype PAAD tissues, while the lowest expression was observed in C3 subtype PAAD tissues (Figure 5G).